Clinical Trials Browser

OTHER × Breast Cancer Female × Standard of Care × Clear all

NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Phase 3 Unknown

Breast Cancer Female